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Recent studies have shown that endogenous serotonin is not required for colonic
peristalsis in vitro, nor gastrointestinal (GI) transit in vivo. However, antagonists of
5-Hydroxytryptamine (5-HT) receptors can inhibit peristalsis and GI-transit in mammals,
including humans. This raises the question of how these antagonists inhibit GI-motility and
transit, if depletion of endogenous 5-HT does not cause any significant inhibitory changes
to either GI-motility or transit? We investigated the mechanism by which 5-HT3 and 5-HT4
antagonists inhibit distension-evoked peristaltic contractions in guinea-pig distal colon. In
control animals, repetitive peristaltic contractions of the circular muscle were evoked
in response to fixed fecal pellet distension. Distension-evoked peristaltic contractions
were unaffected in animals with mucosa and submucosal plexus removed, that were
also treated with reserpine (to deplete neuronal 5-HT). In control animals, peristaltic
contractions were blocked temporarily by ondansetron (1–10µM) and SDZ-205–557
(1–10µM) in many animals. Interestingly, after this temporary blockade, and whilst
in the continued presence of these antagonists, peristaltic contractions recovered,
with characteristics no different from controls. Surprisingly, similar effects were seen
in mucosa-free preparations, which had no detectable 5-HT, as detected by mass
spectrometry. In summary, distension-evoked peristaltic reflex contractions of the circular
muscle layer of the guinea-pig colon can be inhibited temporarily, or permanently, in
the same preparation by selective 5-HT3 and 5-HT4 antagonists, depending on the
concentration of the antagonists applied. These effects also occur in preparations that
lack any detectable 5-HT. We suggest caution should be exercised when interpreting the
effects of 5-HT3 and 5-HT4 antagonists; and the role of endogenous 5-HT, in the generation
of distension-evoked colonic peristalsis.
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INTRODUCTION
Since the early 1950’s, endogenous serotonin release from the gas-
trointestinal (GI) tract has been suggested to play an important
role in the control of different GI motility patterns, such as peri-
stalsis, in the small and large intestine (Büllbring and Lin, 1957,
1958; Büllbring et al., 1958; Grider et al., 1996; Jin et al., 1999;
Heredia et al., 2009). Evidence to support this hypothesis comes
from the fact that the largest quantity of serotonin in the body
is synthesized in enterochromaffin cells (Erspamer, 1954) and
high concentrations of 5-HT can be dynamically released from
the mucosa (Bertrand, 2006; Keating and Spencer, 2010; Spencer
et al., 2011). In addition, it is well known that exogenous 5-HT
potently stimulates GI-motility (Büllbring and Lin, 1957, 1958;
Keating and Spencer, 2010; Spencer et al., 2011) and a variety of
antagonists of 5-HT receptors can potently inhibit, or block peri-
stalsis, reduce transit (Grider et al., 1996; Kadowaki et al., 1996;
Heredia et al., 2009) and rectal distension reflexes (Shimatani
et al., 2003).
Despite significant circumstantial data supporting a role for
endogenous 5-HT in the control of GI-motility, the notion that
endogenous 5-HT plays a major role in control of GI-motility
was substantially revised in the past couple of years, based on
findings from independent laboratories (Yadav et al., 2010; Li
et al., 2011; Spencer et al., 2011; Sia et al., 2013). These recent
studies showed that when 5-HT was depleted from enteric neu-
rons; followed by removal of the mucosa and submucosal plexus,
distension-evoked peristalsis still occurred without any signifi-
cant deficits (Sia et al., 2013). Similar findings have now been
reported for colonic migrating motor complexes (CMMCs) in
the mouse colon (Spencer et al., 2013). Coincidently, recent find-
ings from the laboratory of Gershon and colleagues (Yadav et al.,
2010; Li et al., 2011), demonstrated that deletion of the gene
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responsible for 5-HT synthesis in enterochromaffin (EC) cells
led to no inhibitory effects on GI-transit in live mice (Yadav
et al., 2010; Li et al., 2011). These recent findings are important
because the vast majority of 5-HT in the body (>95%) is syn-
thesized within the intestinal mucosa, with only minor quantities
synthesized in the enteric nervous system. In fact, less than 1%
of enteric neurons have been shown to synthesize 5-HT (Costa
et al., 1996). Also, 5-HT-mediated synaptic potentials are rarely
recorded from myenteric neurons (Galligan et al., 2000; Nurgali
et al., 2003; Furness, 2006). When they have been reported, they
occur in a very small proportion of enteric neurons and are
of small amplitude (Galligan et al., 2000; Nurgali et al., 2003;
Furness, 2006). Studies have shown that 5-HT-mediated fast
synaptic potentials are extremely rare in guinea-pigs (Bornstein
et al., 2004; Furness, 2006); and have never been detected in the
mouse colon (Furukawa et al., 1986; Nurgali et al., 2004), rat small
intestine (Brookes et al., 1988) or human colon (Brookes et al.,
1987). In these species, all fast synaptic potentials in enteric neu-
rons are abolished by nicotinic antagonists, with no serotonergic
fast synaptic potentials being reported. Of particular interest is
why do 5-HT receptor antagonists potently inhibit GI motility
and reduce transit in these same species where no serotonergic
fast EPSPs have been detected (Balfour et al., 2000; Bush et al.,
2001)?
Whilst there is no doubt that antagonists of 5-HT3 and 5-HT4
receptors can delay GI transit in both humans and laboratory
animals, the mechanisms by which these drugs induce their
inhibitory effects on GI-motility is poorly understood. Recently,
we reported that 5-HT3 and 5-HT4 receptors antagonists had
no significant effect on colonic peristalsis in guinea-pig distal
colon, when peristalsis was evoked by acute luminal distension
using fecal pellets, or slow intraluminal fluid distension (Sia et al.,
2013). These results were inconsistent with data obtained from
other laboratories where it was shown that the same 5-HT3 and
5-HT4 antagonists (at the same concentrations) potently inhib-
ited peristalsis, when evoked by the same stimuli in the same
preparation (Kadowaki et al., 1996; Jin et al., 1999). In the current
study, we used a different stimulus to evoke a cyclical peristaltic
contraction. We used maintained distension of the colonic wall,
using an artificial fecal pellet that was not free to be propelled
along the colon. This is an entirely different type of distension
stimulus to that applied in our recent study (Sia et al., 2013). The
primary aim of this study was to determine whether antagonists
of 5-HT3 and 5-HT4 receptors can inhibit distension-evoked
peristaltic contractions, evoked by maintained localized intra-
luminal distension, and if so, what effects would antagonists
of 5-HT3 and 5-HT4 receptors have in preparations that were
depleted of all endogenous 5-HT?
METHODS
PREPARATION OF TISSUES
Adult male guinea pigs, weighing between 350–450 g, were
killed by a blow to the occipital region and exsanguinated,
in a manner approved by the Animal Welfare Committee of
Flinders University. The distal colon (5–10 cm from the anus)
was removed and placed in warm Krebs solution which was con-
stantly bubbled with carbogen gas (95% O2/5% CO2). After a
period of time (usually <20min), fecal pellets naturally present
were expelled from the colon. A segment of distal colon (6 cm in
length) was mounted in an organ bath and left to equilibrate for
30min. After this time, mechanical recordings were made from
the circular muscle using the protocol described below.
TECHNIQUE TO DEPLETE ENDOGENOUS 5-HT FROM THE ENTERIC
NERVOUS SYSTEM
The enteric nervous system was depleted of endogenous 5-HT
using the technique first demonstrated by Costa and Furness
(Costa et al., 1982; Sia et al., 2013). This involves a single subcu-
taneous injection of reserpine (at a concentration of 0.5mg/Kg)
between 18 and 24 h prior to euthanasia. 5-HT immunoreactivity
is not detected in the enteric nervous system after this proce-
dure (Costa et al., 1982). However, because reserpine does not
deplete 5-HT from the mucosa, we further employed our recently
published method (Spencer et al., 2011) to remove the mucosa,
submucosa and submucosal plexus by inverting the colon and
using sharp dissection. This allows us to test whether acute deple-
tion of 5-HT from enteric nerves and the absence of the mucosa
and submucosal plexus impairs colonic motility, without poten-
tial complications such as compensation induced in genetically
modified animals.
TERMINOLOGY USED TO DEFINE DIFFERENT PREPARATIONS
Throughout the results we refer to “control” preparations as those
which were not treated with reserpine and had their mucosa
and submucosal plexus intact. We refer to “reserpine treated—
mucosa present” preparations as those which have been treated
with reserpine and which also have their mucosa and submucosal
plexus present. Preparations that had been treated with reserpine
but also had their mucosa and submucosal plexus removed are
referred to as “reserpine-treated, mucosa removed” preparations.
MECHANICAL RECORDINGS OF CIRCULAR MUSCLE CONTRACTILITY
DURING PERISTALSIS EVOKED BY A FIXED FECAL PELLET
We recorded the isometric force generated by the circular muscle
during each peristaltic contraction by inserting an artificial fecal
pellet into the oral end of colon and allowing the pellet to natu-
rally propagate midway along the length of colon (Spencer et al.,
2011). The pellet was attached to fine surgical cotton thread that
was then fixed in themid region of the preparation so that it could
not be expelled. Cyclical peristaltic contractions were recorded
with an isometric recording transducer Grass (FT-03C; Grass,
Quincy, MA, USA) connected to the ligature. These experiments
were described in the results section as the maintained disten-
sion experiments induced by a fixed pellet, since the pellet was
not free to move along the colon. The isometric force transducers
were connected to two custom made preamplifiers (Biomedical
engineering, Flinders University) and then to a Powerlab (model:
4/30; AD Instruments, Bella Vista, NSW, Australia). Labchart
version 6.0 (AD Instruments, Australia) was used for analysis
of data.
MEASUREMENTS AND STATISTICS
Measurements of the peak amplitude of each peristaltic contrac-
tion were measured from tension recordings, as was the interval
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between each cyclical peristaltic contraction. Data in the results
section are presented as means ± S.E.M. The use of “N” in
the results section refers to the number of animals on which
observations were made. Data sets were considered statistically
significant if P < 0.05. Students unpaired t-test was used to
compare data.
IMMUNOHISTOCHEMISTRY
Isolated segments of guinea-pig distal colon were fixed by
pinning sheet preparations of colon under constant tension
in a Sylgard lined Petri dish (Dow Corning Corp., Midland,
MI, USA) and immersing overnight in Zamboni’s fixative
(5% Formaldehyde and 15% saturated picric acid in 0.1M
phosphate buffer; pH 7.2) at 4◦C. Preparations were then
cleared in dimethyl sulfoxide (10min immersion, repeated
three times), tissue was washed in phosphate buffered saline
(PBS); (0.2M sodium phosphate buffer, pH 7.2) and a
whole mount of the myenteric plexus and longitudinal mus-
cle was prepared by removing the mucosa, submucosa and
circular muscle with the aid of a dissecting microscope.
Goat 5-HT antisera (Immunostar, Cat: 20079) was applied
at 1:1500 overnight at room temperature then washed 3 ×
10min in PBS. Tissue was then incubated for a further
2 h in secondary antisera (Donkey anti Goat CY3; Jackson
Immunoresearch Laboratories Inc) at 1:400 then washed 3 ×
10min in PBS and mounted in bicarbonate- buffered glycerol
(pH 8.6).
DRUGS AND SOLUTIONS
The Krebs solution used contained (in mM): NaCl, 118;
KCl, 4.7; NaHPO4·2H20, 1.0; NaHCO3, 25; MgCl·6H20, 1.2;
D- Glucose, 11; CaCl2·2H20, 2.5. Ondansetron hydrochloride and
SDZ-205–557 were obtained from Sigma Chemical Co. St. Louis.
Mo. USA, and were made up at a stock concentration of 10−2 M.
CHEMICAL ANALYSIS OF TISSUE EXTRACTS FOR 5-HT BY TANDEM
MASS SPECTROMETRY
The amount of 5-HT present in tissues was measured using
solid-phase extraction, reversed-phase liquid chromatography
and electrospray tandem mass spectrometry (LC-MSMS) with
isotope dilution, essentially as described by Tareke et al. (2007).
Liquid chromatography was performed using an Atlantis T3 col-
umn (3µm particle size, 150 × 2.1mm, Waters), while mass
spectrometry used a 3200 Q-Trap instrument (ABSCIEX Toronto,
Canada) tuned to measure ion transitions with m/z 177 > 160
for 5-HT, and 181 > 164 for tetra-deuterated 5-HT as internal
standard. Quantitation was carried out using peak area ratios
and Analyst v. 1.5 software with linear calibration plots cover-
ing the sample concentration range 0–1000 nmol/L. The limit of
quantitation (S/N 5) was 0.5–1 nmol/L.
RESULTS
We investigated the effects of maintained colonic wall distension
by inserting an artificial fecal pellet into the oral end of colon.
The pellet was free to propel anally to a point midway along the
colon, at which point the pellet was fixed in place via fine suture
thread, so that it could not be further expelled, as previously
described (Spencer et al., 2011), (see Figure 1). In response to
maintained distension of control animals with mucosa present,
cyclical peristaltic contractions were evoked at a mean interval
of 278.10 ± 62.3 s (N = 6), or reserpine-treated animals with
mucosa and submucosal plexus removed (398.8 ± 124 s; N = 4;
P = 0.15). This revealed that control mechanisms that regulated
the frequency of peristaltic contractions were independent of the
mucosa or submucosal plexus, or, endogenous 5-HT in enteric
neurons. Similarly, the mean peak amplitude of circular mus-
cle contractions induced during each peristaltic contraction was
10.64 ± 0.8 g in control animals, which, was no different from
reserpine-treated animals with mucosa present (11.4 ± 0.8 g; P =
0.61; N = 16), or reserpine-treated animals with mucosa and
submucosal plexus removed (9.7 ± 1.5 g; P = 0.07; N = 4).
EFFECTS OF 5-HT3 OR 5-HT4 RECEPTOR ANTAGONIST ON
DISTENSION-EVOKED PERISTALTIC CONTRACTIONS
We were particularly interested in the effects of the selective
5-HT3 or 5-HT4 antagonists, ondansetron and SDZ 205–557,
on repetitive peristaltic contractions evoked in control prepa-
rations; and in preparations that were treated with reserpine
but retained mucosa. Initially, we applied ondansetron or SDZ
205–557 to control segments of colon, when reliable peristaltic
contractions were evoked by maintained fixed pellet distension
(e.g., Figure 1A). In most preparations, there was no effect of
either antagonist (Figures 2, 3). However, in a small proportion
of preparations it was found that application of either antagonist
caused an initial blockade of peristaltic contractions (Figure 2).
Surprisingly, in the continued presence of either of these antag-
onists, repetitive peristaltic waves recovered (Figures 2, 3), such
that there was no significant difference in peak amplitude com-
pared to controls (P > 0.05; unpaired Students t-test; N = 5;
Figure 4). When these contractions recovered in the continued
FIGURE 1 | Schematic representation of the method used to evoke
repetitive peristaltic contractions. (A) An artificial fecal pellet is inserted
into the oral end of the isolated colon attached to fine cotton thread. The
pellet was allowed to naturally propel along the colon, until it reached a
point midway along the colon where it was fixed and isometric force
measurements made of the degree of tension generated on the pellet,
during each cyclical peristaltic contraction. (B) Shows a photomicrograph of
the pellet fixed in the colonic lumen. The arrow indicates a robust circular
muscle contraction active on the oral side of the pellet.
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FIGURE 2 | Effects of ondansetron and SDZ 205-557 on a control
colonic preparation. (A) On each occasion when increasing
concentrations of both antagonists were applied a temporary blockade of
peristaltic contractions occurred. However, in the continued presence of
both drugs, contractions recovered with characteristics not detectably
different from controls. (B) Shows that when peristaltic contractions
recovered at 1 and 3µM, the amplitude of these contractions was not
different from control prior to drug addition. (C) Immunohistochemical
staining for 5-HT revealed the presence of immunoreactive varicose axons
in internodal strands and ganglia.
presence of either antagonist, the intervals between contrac-
tions were not significantly different from controls, suggest-
ing that either receptor were not required for their generation
(Figure 5). Only at excessively high concentrations between 5
and 10µM was peristaltic contractions permanently abolished
(Figure 3). Since most preparations were not affected by appli-
cation of either antagonists applied alone, we were interested
in applying both 5-HT3 and 5-HT4 antagonists at the same
time, since it has been suggested that the combined applica-
tion of a 5-HT3 and 5-HT4 receptor antagonist is required to
block peristalsis (Grider et al., 1996; Kadowaki et al., 1996).
Therefore, we tested the effects of both antagonists applied
together.
When both ondansetron or SDZ 205–557 were applied
together at either 1, 3, or 5µM, similar results were obtained
in preparations of colon from control animals; and reserpine-
treated animals with intact mucosa and submucosal plexus
(Figure 6). The primary effect of both these antagonists was
a sudden blockade of repetitive contractions in a proportion
of preparations studied (see Figure 3). The mean duration of
the temporary blockade of both antagonists was 351.2 ± 109.3 s
at 1µM, 375.5 ± 52.1 s at 3µM and 399.0 ± 70.3 s at 5µM
(Figure 6A). With regards to the amplitudes of peristaltic con-
tractions following recovery from a temporary blockade, their
peak amplitudes were also not different from control (P > 0.05;
paired Students t-test; Figures 4, 6B). When peristaltic con-
tractions recovered in the continued presence of these antag-
onists, the intervals between peristaltic contractions revealed
similar findings. For example, in control animals, the average
interval between peristaltic contractions prior to the applica-
tion of antagonists was 278.0 ± 62.3 s (N = 5) and when they
recovered in the presence of these antagonists, the mean inter-
val was 232.4 ± 54.7 s, which was no different from control
intervals (P = 0.86; N = 5). Similarly, following a temporary
blockade at 3µM, ondansetron and SDZ 205–557, the mean
interval between peristaltic contractions which recovered was
219.1 ± 17.2 s (N = 5), but again this was not significantly dif-
ferent from the control interval between peristaltic contrac-
tions, prior to antagonist application (278.0 ± 62.3 s; N = 5;
P = 0.68). Even increasing the concentration of both antago-
nists to 5µM, the interval between peristaltic contractions during
recovery (187.5 ± 50.8 s; N = 5) was not different compared to
control conditions (278.0 ± 62.3 s; N = 4) prior to drug appli-
cation (P = 0.87, N = 4). These observations strongly suggest
that 5-HT3 or 5-HT4 receptor activation is not a prerequisite for
distension-evoked peristaltic contractions to occur.
We incrementally raised the concentration of either
ondansetron or SDZ-205–557 to determine the concentra-
tion of antagonists required to block peristaltic contractions.
It was found to be similar between reserpine-treated (mucosa
intact) animals and controls (Figure 3). Only at high con-
centrations of either antagonist between 5 and 10µM was it
possible to cause permanent blockade of activity in approxi-
mately half of animals studied (see Figure 3). It is noteworthy
that ondansetron at 10µM abolished more preparations (4 of
4 in control and 4 of 5 reserpine-treated, c.f. Figures 3A,B)
compared with SDZ 205–557 alone (3 of 5 in control and 3 of
6 in reserpine-treated, c.f. Figures 3C,D). This means that even
Frontiers in Neuroscience | Autonomic Neuroscience August 2013 | Volume 7 | Article 136 | 4
Sia et al. 5-HT independent peristaltic contractions
FIGURE 3 | Graph shows the number of preparations of colon from
separate animals that showed a temporary or permanent blockade of
peristaltic contractions in control preparations and preparations
obtained from animals treated with reserpine prior to being euthanized.
(A) Shows control animals, a large proportion of preparations showed a
temporary blockade of peristaltic contracions upon application of
ondansetron at increasing concentrations of antagonists applied. (B) Similar
results were obtained in reserpine-treated preparations with mucosa present.
(C) Shows at increasing concentrations of SDZ-205–557 control preparations
and reserpine-treated preparations showed a temporary blockade of
peristaltic contractions (D). At higher concentrations peristaltic contractions
were blocked permanently.
at 10µM SDZ 205-557 approximately half of animals were not
blocked by this excessively high concentration. We confirmed in
reserpine-treated animals that myenteric ganglia were depleted of
neuronal 5-HT, using immunohistochemical staining for 5-HT
(Figure 6C).
EFFECTS OF 5-HT3 AND 5-HT4 RECEPTOR ANTAGONIST ON
PERISTALTIC CONTRACTIONS EVOKED IN PREPARATIONS DEPLETED
OF ALL ENDOGENOUS 5-HT
Of particular interest to us was the combined effect of
ondansetron and SDZ on preparations of colon that had
been reserpine-treated and had their mucosa and submu-
cosal plexus removed (Figure 7). These preparations had no
detectable 5-HT using mass spectrometry, yet interestingly,
application of both antagonists together still had a potent
inhibitory effect on peristaltic contractions (Figure 7). One
striking observation was that in reserpine-treated animals that
also had their mucosa and submucosal plexus removed, com-
bined application of ondansetron and SDZ 205–557 (1µM)
was actually more effective in abolishing these contractions
(Figure 8A) than in control preparations. Fewer preparations
FIGURE 4 | Graph shows mean changes in amplitude of peristaltic
contractions, in response to the combined application of ondansetron
and SDZ-205-557 in three different experimental groups. In control
animals (see filled circles), after an initial blockade of peristaltic contractions
by both antagonists, the amplitude of peristaltic contractions recovered to
amplitudes that were not significantly different from reserpine-treated
animals which had mucosa present (filled squares), or reserpine-treated
that were mucosa-free (filled triangles).
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FIGURE 5 | Effects of application of SDZ-205-557 or ondansetron on
the intervals between repetitive peristaltic contractions. (A) Show a
graphical representation of the responses of individual preparations of
colon to SDZ-205-557. No clear changes are seen. (B) similar lack of
effect of SDZ-205–557 on reserpine treated animals, in which the
mucosa was present. (C) Shows the mean changes in interval between
peristaltic contractions in control (A) and reserpine-treated (B)
preparations overlaid on the same graph. (D) Shows the same
experiment as in (A), but ondansetron is used instead of SDZ-205–557.
Again, no major changes in intervals were detected. (E) Shows the lack
of effect of ondansetron on intervals between peristaltic contractions in
reserpine-treated animals, with mucosa present. (F) Shows mean data
of (D and E) superimposed. No overall significant effects were
detected.
showed a temporary blockade of contractions, followed by recov-
ery. All contractions were abolished at 3µM (Figure 8B). These
major inhibitory effects on peristaltic contractions occurred,
despite the fact that there was no detectable 5-HT in these
preparations.
CONFIRMATION OF DEPLETION OF 5-HT FROM ENTERIC NERVES
USING IMMUNOHISTOCHEMISTRY ANDMASS SPECTROMETRY
Tandem-mass spectrometry was used to quantify the level of
endogenous 5-HT in control colonic specimens and colonic
specimens treated with reserpine. In control specimens,
mass spectrometry was consistently able to detect 5-HT in
concentrations between 1 and 10 nM (mean 1.9 ± 0.31 nM;
N = 4). However, in reserpine-treated segments of colon,
that also had their mucosa and submucosal plexus removed,
mass spectrometry never detected the presence of serotonin
to a sensitivity level of 0.5–1 nM (N = 4). This data was
further independently verified using immunohistochemi-
cal labeling for 5-HT (Costa et al., 1982), in which control
samples of colon always revealed the presence of 5-HT con-
taining varicose fibers. However, in reserpine-treated animals,
immunhistochemical labeling consistently revealed the absence
of any endogenous 5-HT in internodal strands of myenteric
ganglia (Figure 5D).
DISCUSSION
In this study, we evoked repetitive peristaltic contractions in
the distal colon, by maintained intraluminal distension, using
artificial fecal pellets that were fixed within the lumen. This is
an entirely different method of colonic stimulation, compared
to the approach we used in a recent study from our labora-
tory (Sia et al., 2013), where peristaltic contractions were evoked
by insertion of fecal pellets that were free to move along the
colon, or, by slow intraluminal fluid distension that could be
expelled during each peristaltic wave. The major finding of the
current study, is that 5-HT3 and 5-HT4 antagonists can have
significant inhibitory effects on repetitive peristaltic contrac-
tions, evoked by maintained fecal pellet distension. However,
these effects were usually temporary and in most preparations,
peristaltic contractions recovered with normal motor charac-
teristics, even despite continued exposure to the antagonists.
Only at non-specifically high concentrations did these antagonists
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FIGURE 6 | (A) In a reserpine-treated animal with mucosa present, combined
application of SDZ-205-557 and ondansetron caused temporary inhibition of
peristalsitic contractions which recovered even with increasing concentrations
up to 5µM. (B) Shows changes in amplitude of peristaltic contractions from
individual animals. It is apparent that when these contractions recovers the
amplitudes are unaffected in the majority of preparations, even up to 10µM in
concentration. (C) Shows that 5-HT has been depleted from myenteric ganglia
in response to reserpine treatment.
abolish peristaltic contractions and this effect occurred equally
in 5-HT depleted preparations. The new information from
this study is that exposure of increasing concentrations of 5-
HT3 and 5-HT4 antagonists to the colon can cause repeated
temporary blockade of peristaltic contractions of the circu-
lar muscle layer. These findings reveal substantial plasticity in
the intrinsic neural circuitry underlying distension-evoked peri-
staltic reflex motor activity and leads us to propose that cau-
tion should be exercised when assuming a permanent blockade
of motor activity has occurred upon initial exposure to 5-HT
antagonist(s).
EARLY HYPOTHESES REGARDING THE ROLE OF ENDOGENOUS 5-HT IN
COLONIC PERISTALSIS
It has been known for some time that a variety of 5-HT
antagonists can have robust inhibit GI-transit and different
motility patterns in the GI-tract. Despite these well-known
inhibitory effects, there has been considerable speculation regard-
ing the site of action and mechanisms by which these antag-
onists induce their effects. Equally unclear is the mechanism
by which they inhibit GI-motility patterns, such as peristalsis
or cyclical migrating complexes in the small or large intes-
tine. One popular hypothesis has been that 5-HT antago-
nists could act to inhibit GI-motility by inhibiting the release
of endogenous 5-HT from enterochromafiin (EC) cells in
the mucosa, since these cell synthesize large quantities of
5-HT, or, by blocking serotonergic synaptic transmission in
the enteric nervous system. The findings of the current study
suggest this is unlikely to be the case, at least in the distal
colon, since 5-HT3 and 5-HT4 antagonists were still found to
inhibit peristaltic contractions in preparations of colon with
no detectable 5-HT. Our data also shows that the primary
mechanisms by which 5-HT3 and 5-HT4 antagonists inhibit
cyclical peristaltic contractions induced by maintained disten-
sion, must occur independently of the mucosa, or submucosal
plexus.
BY WHATMECHANISM COULD 5-HT ANTAGONISTS CAUSE
TEMPORARY OR SUSTAINED INHIBITION OF PERISTALTIC
CONTRACTIONS IN PREPARATIONSDEPLETED OF ENDOGENOUS 5-HT?
A major finding of the current study was that in the major-
ity of preparations, the presence of ondansetron and/or SDZ
205-557 caused a rapid blockade of peristaltic contractions.
However, in the continuous presence of the drugs, peristaltic
contractions gradually recovered had had characteristics not
significantly different from controls. The fact that peristalsis
contractions still occurred robustly in reserpine-treated ani-
mals, with mucosa and submucosal plexus removed confirms
our previous work that endogenous 5-HT was not required
for the peristalsis. The major new findings of this study is
that the antagonists potently inhibited peristaltic contractions
in 5-HT depleted preparations showed that the antagonists did
not require release of endogenous 5-HT for their inhibitory
effects to occur (Figure 7A). One possible explanation for these
findings is that 5-HT3 and 5-HT4 receptors may be consti-
tutively active in the absence of any endogenous ligand (i.e.,
5-HT). This would explain why the antagonists could still
potently inhibit contractions, without any endogenous 5-HT
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FIGURE 7 | (A) In a reserpine-treated animal, with mucosa and
submucosal plexus removed, the combined application of SDZ-205-557
and ondansetron had potent inhibitory effects on peristaltic contractions,
even despite the lack of any 5-HT detected in these preparations with
mass spectrometry or immunohistochemistry. The recording shows that
peristalsis slows at 1µM and is abolished at 3µM. (B) Graph shows
that 5-HT depleted preparations showed greater sensitivities to both
antagonists. All preparations were permanently abolished by both
antagonists at 3µM. (C), immunohistochemistry confirmed the absence
of 5-HT in myenteric ganglia and internodal strands.
being present in the colon. Indeed, the ligand-gated 5-HT3
receptor (Hu and Peoples, 2008) and the G-protein coupled 5-
HT4 (Berthouze et al., 2005) receptor have both been reported
to display constitutive activity. If the antagonists reduce this con-
stitutive activity (acting as inverse agonists), this could reduce
the background excitability of the enteric neurons that express
these receptors and inhibit the neuronal circuitry required for
this motor pattern to occur. The reason for the recovery of peri-
staltic contractions in the continued presence of the antagonists
is remarkably similar to the results we reported with hexam-
ethonium, which also temporarily blocked peristalsis, then recov-
ered (Nicholas and Spencer, 2010). We speculate that a sudden
reduction of activity in enteric circuits, evoked by antagonists,
may be followed by a gradual increase in neuronal excitability
that partially compensates, explaining why peristaltic contrac-
tions recover. This mechanism would not require endogenous
5-HT.
WHY DO THE SAME 5-HT3 AND 5-HT4 ANTAGONISTS HAVE DIFFERENT
EFFECTS ON PERISTALTIC CONTRACTIONS EVOKED IN THE SAME
PREPARATION OF DISTAL COLON?
In a recent study (Sia et al., 2013), we showed that the combined
presence of ondansetron and SDZ-205–557 had no significant
effect on distension-evoked peristalsis in isolated guinea-pig distal
colon. In that study, we evoked peristalsis via a different method
to the method using in this current study. In our recent study (Sia
et al., 2013), we evoked peristalsis by slow constant fluid infu-
sion, or acutely inserted fecal pellets. In these cases, intraluminal
contents were free to be propelled along the colon and expelled
by each peristaltic wave. In contrast, in the current study, we
recorded peristaltic contractions that were evoked by maintained
colonic wall distension, by a fixed fecal pellet that was not free
to be propelled along the colon. Interestingly, despite using the
same region of colon from the same species, we found that the
same antagonists had very different effects on the two different
patterns of motor activity evoked. Why the same antagonists,
used at the same concentrations, had different effects is unclear.
What is clear is that the inhibitory effects we recorded in the
current study are unlikely to be due to the blockade of endoge-
nous 5-HT acting on either 5-HT3 or 5-HT4 receptors. This is
because the inhibitory effects of these antagonists occurred in
colonic preparations that had no detectable 5-HT. This is highly
consistent with our recent conclusions and data which showed
that endogenous 5-HT was not required for peristalsis (Sia et al.,
2013). If the peristaltic contractions were blocked by 5-HT3 and
5-HT4 antagonists because endogenous 5-HT was required for
their activation, then depletion of all endogenous 5-HT would
be expected to cause the same inhibitory effects. This did not
happen. We found no significant deficits in distension-evoked
peristaltic contractions in 5-HT depleted preparations. This leads
us to believe that the selective 5-HT3 and 5-HT4 antagonists
were acting on their cognate receptors to change the excitabil-
ity of the enteric nervous system, independent of the presence of
endogenous 5-HT. Indeed, similar effects were also reported with
ondansetron on CMMCs in the isolated mouse colon, where it
was found that in mucosa-free colonic preparations treated with
reserpine, ondansetron was actually significantlymore effective at
inhibiting CMMCs (Spencer et al., 2013).
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FIGURE 8 | Sensitivity of individual experiments to the combined effects
of receptor antagonists to 5-HT3 and 5-HT4 receptors. (A) Shows control
data of the proportion of individual colonic preparations that showed repeated
temporary blockade of repetitive peristaltic contractions with increasing
concentrations of SDZ-205–557 and ondansetron. The table shows
responses of 6 control animals to consecutive application of increasing
concentrations of ondansetron and ondansetron (1–10µM) and responses to
4 preparations treated with reserpine and also with mucosa and submucosal
plexus removed. Interestingly, in reserpinized preparations, with mucosa and
submucosal plexus removed, peristaltic contractions rarely recovered in the
presence of both antagonists and most 3 of 4 animals were blocked at 1µM,
whereas in control animals, 4 out of 6 animals required 10µM to
permanently block these contractions. In (A), it can be seen that 1 out 6
preparations was abolished at 1µM of these antagonists, then increasing the
concentration to 5µM one additional preparation was blocked, then the
remaining 4 preparations were all blocked at 10µM. (B) In contrast, in
reserpine-treated mucosa-free preparations, no preparations were blocked at
1µM, but all were abolished at 3µM.
CONCLUSIONS
The findings of the current study show, for the first time,
that repetitive peristaltic contractions induced by maintained
colonic wall distension can be temporarily inhibited by antago-
nists of 5-HT3 and 5-HT4 receptors; and these effects occurred
equally in preparations that lack any endogenous 5-HT. Only
at non-physiologically high concentrations do these antago-
nists abolish peristaltic contractions. Taken together, none of
our findings suggest that the generation of distension-evoked
peristaltic contractions in guinea-pig colon requires physiolog-
ical activation of 5-HT3 or 5-HT4 receptors by endogenous
5-HT. We suggest caution should be exercised when inter-
preting the initial effects of specific 5-HT3 and 5-HT4 recep-
tor antagonists on the generation of peristaltic reflex motor
activity.
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